drugset / Trial / NCT00579553

Comparing IM vs. Vaginal Progesterone for Pre-term Birth

NCT00579553

Completed 174 enrolled University of Oklahoma
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a randomized controlled trial comparing weekly intramuscular injection of 17 alpha hydroxylprogesterone caproate with daily vaginal progesterone in women with singleton pregnancies and history of prior spontaneous preterm birth in terms of maternal, fetal and neonatal outcomes. Our aim is to assess the effects on maternal, fetal and neonatal outcomes of antenatal progesterone administered intramuscularly versus vaginally in women with singleton pregnancy and a history of prior preterm birth.

Timeline

Start
2006-10
Primary completion
2011-05
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Subject 17-alpha-hydroxyprogesterone caproate Unknown 250 mg Intramuscular
Subject Progesterone Other / unclassified 100 mg Intravenous

Indications

No indication recorded.